Cargando…

The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H.pylori: a randomized controlled trial

AIM: Evaluating the efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of Helicobacter pylori. BACKGROUND: Several probiotics such as Saccharomyces boulardii have been investigated for their clinical efficacy. This probiotic, inhibit H. pylo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zojaji, Homayoun, Ghobakhlou, Mehdi, Rajabalinia, Hassan, Ataei, Elnaz, Jahani Sherafat, Somayeh, Moghimi-Dehkordi, Bijan, Bahreiny, Rasoul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research Institute for Gastroenterology and Liver Diseases 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017538/ https://www.ncbi.nlm.nih.gov/pubmed/24834296

Ejemplares similares

The effect of the treatment of Helicobacter pylori infection on the glycemic control in type 2 diabetes mellitus
por: Zojaji, Homayon, et al.
Publicado: (2013)

Evaluation of the benefit of addition of clidinium C to a Helicobacter pylori eradication regimen
por: Chorami, Maryam, et al.
Publicado: (2013)

Non-Helicobacter pylori, non-NSAIDs peptic ulcers: a descriptive study on patients referred to Taleghani hospital with upper gastrointestinal bleeding
por: Rajabalinia, Hasan, et al.
Publicado: (2012)

A comparative study of broccoli sprouts powder and standard triple therapy on cardiovascular risk factors following H.pylori eradication: a randomized clinical trial in patients with type 2 diabetes
por: Mirmiran, Parvin, et al.
Publicado: (2014)

Food bioactive componts, a possible adjuvant for H.pylori eradication
por: Ebrahimpour, Soheil, et al.
Publicado: (2017)

Association of Helicobacter pylori with central serous chorioretinopathy in Iranian patients
por: Roshani, Mohammad, et al.
Publicado: (2014)

Facing resistance of H.pylori infection
por: Zali, Mohammad Reza
Publicado: (2011)

Duodenal adenocarcinoma might be the cause of intractable nausea and vomiting in patient with coeliac disease
por: Rajabalinia, Hassan, et al.
Publicado: (2012)

Effect of metformin on the eradication of H.Pylori infection in 25 -75 years old patients referring Loghman Hakim Hospital
por: Nikpour, Shahriar, et al.
Publicado: (2022)

Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer
por: Qiu, Hai-Bo, et al.
Publicado: (2010)

Elucidation of the conformational free energy landscape in H.pylori LuxS and its implications to catalysis
por: Bhattacharyya, Moitrayee, et al.
Publicado: (2010)

Anxiety and Depression in a Sample of Iranian Patients With Irritable Bowel Syndrome
por: Farzaneh, Neda, et al.
Publicado: (2013)

Evaluation of Psychological Aspects Among Subtypes of Irritable Bowel Syndrome
por: Farzaneh, Neda, et al.
Publicado: (2012)

Psychological features in patients with and without irritable bowel syndrome: A case–control study using Symptom Checklist-90-Revised
por: Farbod, Fadai, et al.
Publicado: (2015)

Effect of Xeroderma pigmentosum complementation group F polymorphisms and H.pylori infection on the risk of gastric cancer
por: Zhang, Li-li, et al.
Publicado: (2013)

Comprehensive Analysis of Aberrantly Expressed ceRNA network in gastric cancer with and without H.pylori infection
por: Chu, Aining, et al.
Publicado: (2019)

Comparison of half-dose and full-dose triple therapy regimens for Helicobacter pylori eradication in patients with end-stage renal disease
por: Ehsani Ardakani, Mohammad Javad, et al.
Publicado: (2014)

Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis
por: Han, Fang, et al.
Publicado: (2016)

Relationship of Halitosis with Gastric Helicobacter Pylori Infection
por: HajiFattahi, Farnaz, et al.
Publicado: (2015)

Therapeutic response to ramucirumab + folfiri in patients with metastatic gastric cancer
por: Rezvani, Hamid, et al.
Publicado: (2022)

NaCl pretreatment attenuates H.pylori-induced DNA damage and exacerbates proliferation of gastric epithelial cells (GES-1)
por: Xu, Ying, et al.
Publicado: (2015)

H.pylori associated with iron deficiency anemia even in celiac disease patients; strongly evidence based but weakly reflected in practice
por: Rostami-Nejad, Mohammad, et al.
Publicado: (2015)

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H.pylori immunostimulatory bacterial transgene
por: Viker, Kimberly B., et al.
Publicado: (2022)

ABO, Lewis blood group systems and secretory status with H.pylori infection in yemeni dyspeptic patients: a cross- sectional study
por: Almorish, Mohammed Abdulwahid, et al.
Publicado: (2023)

Saccharomyces Boulardii in Helicobacter Pylori Eradication in Children: A Randomized Trial From Iran
por: Namkin, Kokab, et al.
Publicado: (2016)

The impacts of probiotics in eradication therapy of Helicobacter pylori
por: Bai, Xiaofen, et al.
Publicado: (2022)

A Comprehensive Review of the Role of Complementary and Dietary Medicines in Eradicating Helicobacter pylori
por: Abdi, Saeed, et al.
Publicado: (2022)

The effects of probiotics on the treatment of Helicobacter pylori eradication in children
por: Al-Mendalawi, Mahmood D.
Publicado: (2015)

The effects of probiotics on treatment of Helicobacter pylori eradication in children
por: Akcam, Mustafa, et al.
Publicado: (2015)

Effectiveness of including probiotics to Helicobacter pylori eradication therapies
por: Mukai, Rieko, et al.
Publicado: (2020)

The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children
por: Bin, Zhang, et al.
Publicado: (2015)

Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients
por: Bahadoran, Zahra, et al.
Publicado: (2015)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

H. pylori Eradication Therapy
por: Hsu, Ping-I, et al.
Publicado: (2013)

Nutrients and probiotics: current trends in their use to eradicate Helicobacter pylori
por: Handa, Osamu, et al.
Publicado: (2020)

The Challenges of Eradicating Pediatric Helicobacter pylori Infection in the Era of Probiotics
por: Meliț, Lorena Elena, et al.
Publicado: (2022)

Low Dose Furazolidone for Eradication of Helicobacter pylori Instead of Clarithromycin: A Clinical Trial
por: Hajaghamohammadi, Aliakbar, et al.
Publicado: (2015)

Down-regulation of TP53 is a highlighted molecular event in gastric ulcer
por: Vafaee, Reza, et al.
Publicado: (2022)

Occurrence of Helicobacter pylori and its major virulence genotypes in dental plaque samples of patients with chronic periodontitis in Iran
por: Valadan Tahbaz, Sahel, et al.
Publicado: (2017)

The early efficacy of Heller myotomy in the treatment of Iranian patients with achalasia
por: Abdi, Saeed, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5s6otijei8bi2ctcptvprumbk4